Professor Elijah Behr

Elijah Behr is an international expert in the field of arrhythmias and is Professor in Cardiovascular Medicine at City St. George’s, University of London where he directs the Cardiovascular and Genomics Research Institute. He is a Consultant at St. George’s University Hospitals NHS Foundation Trust and Mayo Clinic Healthcare, London, where he leads nationally, and internationally reputed clinical services dedicated to patients with arrhythmias, and patients and their families with genetic risks for arrhythmia, cardiac arrest and sudden death. He has co-written multiple international guideline documents.

He is past president of the Association for Inherited Cardiac Conditions and the first chairperson of the European Cardiac Arrhythmia Genetics Group of EHRA. He is first chair of the Predisposition and Screening Genome England Clinical Interpretation Partnership and has advised the NHS England Clinical Reference Groups for Cardiovascular and Genomics Services. He leads the NHS England Coronial Sudden Unexpected Death Pilot and National roll-out.

He leads a research group with interests that include the genomics and prediction of sudden death risk; drug-induced arrhythmia; the Sudden Arrhythmic Death Syndrome (SADS) and Sudden Infant Death Syndrome (SIDS); channelopathies including long QT and Brugada syndromes; and arrhythmogenic cardiomyopathy. He has published over 300 articles in peer reviewed journals.